Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma

Urology
Sheila F FarajGeorge J Netto

Abstract

To evaluate programmed death ligand 1 (PD-L1) expression in urothelial carcinoma of the bladder in relationship with tumor-infiltrating CD8+ T cells. Tissue microarrays were prepared from 56 cystectomy specimens performed at our hospital (1994-2002). PD-L1 immunoexpression was assessed using the murine antihuman PD-L1 monoclonal antibody 5H1. Extent of membranous PD-L1 expression was assigned in each spot. Spots showing ≥5% expression were considered positive. Average PD-L1 expression per tumor was also calculated (5% positivity cutoff). "High CD8 density" was defined as the presence of ≥60 CD8+ intraepithelial lymphocytes per high power field in a given spot. A tumor was considered high density if ≥50% of its spots were of high density. PD-L1 expression was positive in approximately 20% of tumors. None of the benign urothelium spots expressed PD-L1. High CD8 density was observed in approximately 20% of cases. CD8 density did not correlate with PD-L1 expression. Overall survival (OS) and disease-specific survival (DSS) rates were 14% and 28%, respectively (median follow-up, 31.5 months). PD-L1 expression was associated with age at cystectomy (P = .01). Remaining clinicopathologic parameters were not associated with PD-L1 expres...Continue Reading

References

Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jun KonishiMasaharu Nishimura
Dec 24, 2005·The New England Journal of Medicine·Franck PagèsJérôme Galon
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Padmanee SharmaEiichi Sato
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takeo NomiYoshiyuki Nakajima
Aug 19, 2007·The Journal of Urology·Harry W HerrVictor E Reuter
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
Aug 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephen A BoorjianIgor Frank
Oct 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert L CampDavid L Rimm
Oct 15, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rezaul KarimSjoerd H van der Burg
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Jan 13, 2012·Current Opinion in Immunology·Suzanne L TopalianDrew M Pardoll
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Sep 5, 2013·JAMA : the Journal of the American Medical Association
Sep 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mario Sznol, Lieping Chen
Jan 10, 2014·Cancer Medicine·David F McDermott, Michael B Atkins

❮ Previous
Next ❯

Citations

Jan 24, 2017·Annales de pathologie·Virginie VerkarreYves Allory
Dec 23, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Maria TretiakovaAllen Gown
Nov 22, 2017·Journal for Immunotherapy of Cancer·David H Aggen, Charles G Drake
Feb 19, 2019·American Journal of Clinical Pathology·Aileen Grace P ArriolaPriti Lal
Jul 15, 2015·British Journal of Cancer·C D FankhauserP K Bode
Dec 2, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Janis M TaubeAshley Cimino-Mathews
Dec 6, 2017·Nature Reviews. Urology·Arlene Siefker-Radtke, Brendan Curti
Jan 24, 2018·The Cancer Journal·Matthew C Dallos, Charles G Drake
Sep 22, 2019·International Urology and Nephrology·Ismail SelviHalil Basar
Nov 30, 2018·Asia-Pacific Journal of Clinical Oncology·Di Maria Jiang, Srikala S Sridhar
Jul 3, 2019·International Journal of Molecular Sciences·Huang-Yu YangKun-Lin Lu
Nov 7, 2019·International Journal of Molecular Sciences·Fabio PagniNicola Fusco
Nov 19, 2017·Cancer Immunology, Immunotherapy : CII·Johannes BreyerArndt Hartmann
Jan 7, 2021·Cancers·Antonio Lopez-BeltranRodolfo Montironi
Mar 28, 2020·Current Drug Targets·Kerstin JunkerRodolfo Montironi
Mar 13, 2021·Targeted Oncology·Enrique GrandeAndrea Necchi
Mar 20, 2021·Cancer Immunology, Immunotherapy : CII·Chien-Hsu ChenPo-Hui Chiang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.